Temocapril - Daiichi Sankyo Company
Alternative Names: Acecol; CS 622; RS 5139; RS 5142Latest Information Update: 05 Nov 2023
At a glance
- Originator Daiichi Sankyo Company
- Developer Boehringer Ingelheim; Daiichi Sankyo Company
- Class Antihypertensives; Thiazepines
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hypertension